Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	9.7	0.46	16.58	0	0.02
Cash & Cash Equivalents	9.7	0.46	16.58	0	0.02
Cash Growth	2032.09%	-97.26%	-	-	-
Other Current Assets	3.7	2.19	1.83	0.2	0
Total Current Assets	13.4	2.64	18.41	0.2	0.02
Property, Plant & Equipment	0.79	0.17	0.33	0	0
Total Long-Term Assets	0.79	0.17	0.33	0	0
Total Assets	14.19	2.82	18.74	0.2	0.02
Accounts Payable	0.84	0.89	0.74	0.19	0.43
Current Debt	0.33	0.16	0.15	2.51	0.46
Other Current Liabilities	16.37	2.24	1.21	0.17	0.01
Total Current Liabilities	17.53	3.28	2.11	2.88	0.9
Long-Term Debt	0.47	0	0.16	0	0
Total Long-Term Liabilities	0.47	0	0.16	0	0
Total Liabilities	18	3.28	2.26	2.88	0.9
Total Debt	0.79	0.16	0.31	2.51	0.46
Debt Growth	411.61%	-49.35%	-87.83%	446.52%	-
Retained Earnings	-64.54	-34	-15.94	-5.92	-3.66
Shareholders' Equity	-3.81	-0.47	16.48	-2.67	-0.88
Net Cash / Debt	8.91	0.3	16.27	-2.51	-0.45
Net Cash / Debt Growth	2869.33%	-98.16%	-	-	-
Net Cash Per Share	0.36	0.02	1.39	-0.30	-0.05
Working Capital	-4.14	-0.64	16.31	-2.67	-0.88
Book Value Per Share	-0.15	-0.03	1.41	-0.31	-0.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).